Skip to main content
. 2022 Sep 14;13:1017120. doi: 10.3389/fimmu.2022.1017120

Figure 9.

Figure 9

Selecting suitable drugs for high-risk group patients with OS via OncoPredict. (A) OncoPredict was used to transform the gene expression profile of OS tissues in the TARGET and GSE21257 groups into a drug sensitivity matrix of 198 drugs. (B) Resistant drugs identified in high-risk groups in both the TARGET and GSE21257 cohorts. (C) Sensitive drugs identified in high-risk groups in the TARGET and GSE21257 cohorts.